Shawa, Misheck
Furuta, Yoshikazu
Mulenga, Gillan
Mubanga, Maron
Mulenga, Evans
Zorigt, Tuvshinzaya
Kaile, Christone
Simbotwe, Manyando
Paudel, Atmika
Hang’ombe, Bernard
Higashi, Hideaki
Funding for this research was provided by:
Japan Society for the Promotion of Science (17H01679, 18K19436, 18K14672)
Japan Initiative for Global Research Network on Infectious Diseases
World-leading Innovative and Smart Education
Japan International Cooperation Agency
Article History
Received: 15 December 2020
Accepted: 21 April 2021
First Online: 10 May 2021
Declarations
:
: Ethical approval was granted by Excellence in Research Ethics and Science Converge with clearance number 2015-Feb-018, while Biological Transfer permit was approved by the National Health Research Ethics Board. All strains used in this study were isolated at the UTH during routine clinical investigations. The strains were identified on the basis of resistance to cefotaxime during routine susceptibility tests. Patient personal and clinical data were anonymized and unlinked to patient identifiers.
: Not applicable.
: The authors declare that they have no competing interests.